Please check your internet connection and try again.
# Megacv Duo (Amoxicillin / Clavulanate Potassium)
## Overview
Megacv Duo is a combination penicillin-class antibiotic consisting of amoxicillin (a beta-lactam) and clavulanate potassium (a beta-lactamase inhibitor). The addition of clavulanate expands the spectrum of activity against beta-lactamase-producing organisms.
## Primary Indications
* Community-acquired pneumonia
* Acute bacterial sinusitis
* Acute otitis media
* Skin and skin-structure infections
* Urinary tract infections
* Lower respiratory tract infections
## Adult Dosing
* **Standard dose:** 875 mg amoxicillin / 125 mg clavulanate every 12 hours.
* **Severe infection/Respiratory tract:** 875 mg amoxicillin / 125 mg clavulanate every 8 to 12 hours.
* *Note:* Dose for amoxicillin/clavulanate is typically expressed based on the amoxicillin component.
## Pediatric Dosing
* **Acute Otitis Media/Pneumonia:** 90 mg/kg/day (based on amoxicillin component) divided every 12 hours using the 4:1, 7:1, or 14:1 ratio formulations.
* **Max dose:** Do not exceed the maximum daily adult dose.
* *Warning:* Use the specific concentration formulation to ensure the ratio of clavulanate does not cause excessive diarrhea/GI distress.
## Dose Adjustments
* **Renal Impairment:** If CrCl < 30 mL/min, the extended-release formulation (875 mg/125 mg) is contraindicated. For immediate-release products, adjust interval or decrease dose based on CrCl level (< 30 mL/min: avoid high-dose formulations or increase dosing interval).
* **Hepatic Impairment:** Use with caution; monitor hepatic function periodically.
## Contraindications
* History of cholestatic jaundice or hepatic dysfunction associated with previous use of amoxicillin/clavulanate.
* Severe hypersensitivity (anaphylaxis) to any penicillin or cephalosporin (cross-reactivity risk).
* Phenylketonuria (some chewable formulations contain phenylalanine).
## Adverse Effects
* **Common:** Diarrhea, nausea, vomiting, abdominal pain, skin rash/urticaria.
* **Serious:** *Clostridioides difficile*-associated diarrhea (CDAD), hepatotoxicity (cholestatic jaundice), severe hypersensitivity reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis).
## Key Drug Interactions
* **Methotrexate:** Amoxicillin may decrease renal clearance of methotrexate, increasing toxicity risk.
* **Warfarin:** May increase INR/bleeding risk due to alteration of gut flora (vitamin K synthesis).
* **Oral Contraceptives:** May reduce efficacy (though clinical data is mixed; backup contraception recommended).
* **Allopurinol:** Increased risk of skin rash.
## Monitoring
* Monitor for signs of anaphylaxis during the first dose.
* Assess renal and hepatic function during prolonged therapy.
* Monitor for watery or bloody diarrhea (symptoms of *C. difficile*).
## Clinical Pearls
* **Administration:** Administer with food at the start of a meal to reduce gastrointestinal side effects and improve absorption.
* **Dosing Ratio:** Ensure the correct ratio is selected; the clavulanate component is fixed, and using too many lower-dose tablets can lead to excessive clavulanate intake, significantly increasing diarrhea risk.
* **Resistance:** Not effective against MRSA or other resistant organisms (e.g., *Pseudomonas*).
***
**Educational Disclaimer:** This information is for educational purposes and does not replace professional clinical judgment. Always verify dosages, contraindications, and local institutional prescribing guidelines against current package inserts and authoritative drug databases such as Lexicomp or Micromedex before prescribing or administering medication.
